MYX mayne pharma group limited

Ann: Mayne Pharma investor presentation to Goldmans conference, page-6

  1. 843 Posts.
    lightbulb Created with Sketch. 82
    Nuvaring- As per mithra pharmaceuticals FDA approval expected 4th quarter 2019 or 1st qt 2020

    How about Fentora and Patch which we have already filed with FDA??
    Does anyone know anything about these drugs??

    Any queries from FDA?? Timeline??
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.25
Change
-0.150(2.78%)
Mkt cap ! $426.5M
Open High Low Value Volume
$5.35 $5.41 $5.19 $1.239M 231.7K

Buyers (Bids)

No. Vol. Price($)
1 1000 $5.17
 

Sellers (Offers)

Price($) Vol. No.
$5.36 1000 1
View Market Depth
Last trade - 16.11pm 25/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.